Follow
Eric A Mellon MD, PhD
Eric A Mellon MD, PhD
University of Miami, Miller School of Medicine, Sylvester Comprehensive Cancer Center
Verified email at med.miami.edu
Title
Cited by
Cited by
Year
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
M Suker, BR Beumer, E Sadot, L Marthey, JE Faris, EA Mellon, ...
The Lancet Oncology 17 (6), 801-810, 2016
8932016
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
JG Scott, A Berglund, MJ Schell, I Mihaylov, WJ Fulp, B Yue, E Welsh, ...
The lancet oncology 18 (2), 202-211, 2017
4242017
Sodium and T MRI for molecular and diagnostic imaging of articular cartilage
A Borthakur, E Mellon, S Niyogi, W Witschey, JB Kneeland, R Reddy
NMR in Biomedicine: An International Journal Devoted to the Development and …, 2006
3952006
Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated
MD Chuong, GM Springett, JM Freilich, CK Park, JM Weber, EA Mellon, ...
International Journal of Radiation Oncology* Biology* Physics 86 (3), 516-522, 2013
3922013
Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis
QP Janssen, S Buettner, M Suker, BR Beumer, P Addeo, P Bachellier, ...
JNCI: Journal of the National Cancer Institute 111 (8), 782-794, 2019
2892019
Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer
S Rudra, N Jiang, SA Rosenberg, JR Olsen, MC Roach, L Wan, ...
Cancer medicine 8 (5), 2123-2132, 2019
2782019
Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma
EA Mellon, SE Hoffe, GM Springett, JM Frakes, TJ Strom, PJ Hodul, ...
Acta oncologica 54 (7), 979-985, 2015
2462015
Artifacts in T1ρ-weighted imaging: Compensation for B1 and B0 field imperfections
WRT Witschey II, A Borthakur, MA Elliott, E Mellon, S Niyogi, DJ Wallman, ...
Journal of magnetic resonance 186 (1), 75-85, 2007
1852007
Sodium MR imaging detection of mild Alzheimer disease: preliminary study
EA Mellon, DT Pilkinton, CM Clark, MA Elliott, WR Witschey, A Borthakur, ...
American Journal of Neuroradiology 30 (5), 978-984, 2009
1332009
Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant …
EA Mellon, WH Jin, JM Frakes, BA Centeno, TJ Strom, GM Springett, ...
Acta Oncologica 56 (3), 391-397, 2017
782017
Dosimetric benefits and practical pitfalls of daily online adaptive MRI-guided stereotactic radiation therapy for pancreatic cancer
N El-Bared, L Portelance, BO Spieler, D Kwon, KR Padgett, KM Brown, ...
Practical radiation oncology 9 (1), e46-e54, 2019
742019
A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy±intensity modulated radiation therapy
TJ Strom, RB Wilder, DC Fernandez, EA Mellon, AS Saini, DC Hunt, ...
Radiotherapy and Oncology 111 (1), 126-131, 2014
652014
Persistent TrkA activity is necessary to maintain transcription in neuronally differentiated PC12 cells
JH Chang, E Mellon, NC Schanen, JL Twiss
Journal of Biological Chemistry 278 (44), 42877-42885, 2003
612003
Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with …
EA Mellon, TJ Strom, SE Hoffe, JM Frakes, GM Springett, PJ Hodul, ...
Journal of gastrointestinal oncology 7 (4), 547, 2016
542016
Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer
MD Chuong, JM Frakes, N Figura, SE Hoffe, R Shridhar, EA Mellon, ...
Journal of gastrointestinal oncology 7 (2), 221, 2016
482016
Personalizing radiotherapy prescription dose using genomic markers of radiosensitivity and normal tissue toxicity in NSCLC
JG Scott, G Sedor, JA Scarborough, MW Kattan, J Peacock, GD Grass, ...
Journal of Thoracic Oncology 16 (3), 428-438, 2021
462021
Daily tracking of glioblastoma resection cavity, cerebral edema, and tumor volume with MRI-guided radiation therapy
S Mehta, SR Gajjar, KR Padgett, D Asher, R Stoyanova, JC Ford, ...
Cureus 10 (3), 2018
462018
A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer
EA Mellon, K Javedan, TJ Strom, EG Moros, MC Biagioli, DC Fernandez, ...
Practical Radiation Oncology 5 (1), 11-15, 2015
432015
Estimation of the regional cerebral metabolic rate of oxygen consumption with proton detected 17O MRI during precision 17O2 inhalation in swine
EA Mellon, RS Beesam, JE Baumgardner, A Borthakur, WR Witschey 2nd, ...
Journal of neuroscience methods 179 (1), 29-39, 2009
402009
The Brain Imaging Collaboration Suite (BrICS): a cloud platform for integrating whole-brain spectroscopic MRI into the radiation therapy planning workflow
S Gurbani, B Weinberg, L Cooper, E Mellon, E Schreibmann, S Sheriff, ...
Tomography 5 (1), 184-191, 2019
392019
The system can't perform the operation now. Try again later.
Articles 1–20